Acta Neurol Scand
- MAHAMUD Z, Burman J, Zelano J
Temporal trends of epilepsy in multiple sclerosis.
Acta Neurol Scand. 2022 Jul 18. doi: 10.1111/ane.13671.
Brain
- EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
Sex differences in the genetic architecture of cognitive resilience to
Alzheimer's disease.
Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
Int J Neurosci
- KHORRAMI M, Saneipour M, Moridnia A, Shaygannejad V, et al
Interdependency of NINJ2 gene expression and polymorphism with susceptibility and
response to Interferon Beta in patients with Multiple Sclerosis.
Int J Neurosci. 2022 Aug 1:1-9. doi: 10.1080/00207454.2022.2102979.
J Neuroimmunol
- ALOISI F, Cross AH
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and
pathogenesis.
J Neuroimmunol. 2022;371:577935.
- FUCHS L, Mausner-Fainberg K, Luban A, Asseyer SE, et al
CTGF/CCN2 has a possible detrimental role in the inflammation and the
remyelination failure in the early stages of multiple sclerosis.
J Neuroimmunol. 2022;371:577936.
J Neurol
- KREFT KL, Robertson NP
Innovative biomarkers to predict unfavourable outcomes after initiating multiple
sclerosis treatment.
J Neurol. 2022 Aug 1. pii: 10.1007/s00415-022-11300.
J Neurol Neurosurg Psychiatry
- CHEN J, Diouf I, Taylor BV, Kalincik T, et al
Superior effects of natalizumab versus other DMTs on patient-reported outcomes in
people with multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2022 Jul 28. pii: jnnp-2022-329223.
- KWON S, Jung SY, Han KD, Jung JH, et al
Risk of Parkinson's disease in multiple sclerosis and neuromyelitis optica
spectrum disorder: a nationwide cohort study in South Korea.
J Neurol Neurosurg Psychiatry. 2022 Jul 28. pii: jnnp-2022-329389.
J Neurol Sci
- HARIRCHIAN MH, Zahednasab H, Karampoor S
The enigmatic role of macrophage inhibitory factor (MIF) in the pathogenesis of
multiple sclerosis (MS).
J Neurol Sci. 2022;440:120351.
- MERMELSTEIN M, Naftali J, Wilf-Yarkoni A, Lotan I, et al
Repeated lumbar puncture in search of oligoclonal bands - What is the yield?
J Neurol Sci. 2022;439:120298.
Mult Scler
- TAGGE IJ, Leppert IR, Fetco D, Campbell JS, et al
Permanent tissue damage in multiple sclerosis lesions is associated with reduced
pre-lesion myelin and axon volume fractions.
Mult Scler. 2022 Jul 28:13524585221110585. doi: 10.1177/13524585221110585.
Nat Rev Neurol
- FILIPPI M, Preziosa P
MRI predicts cognitive training effects in multiple sclerosis.
Nat Rev Neurol. 2022 Aug 1. pii: 10.1038/s41582-022-00701.
Neurologia (Engl Ed)
- BROCHE-PEREZ Y, Jimenez-Morales RM, Monasterio-Ramos LO, Vazquez-Gomez LA, et al
Fear of Relapse Scale: Spanish version and psychometric characteristics in a
sample of patients with Relapsing-Remitting Multiple Sclerosis.
Neurologia (Engl Ed). 2022 Jul 27. pii: S2173-5808(22)00080.
Neurology
- BSTEH G, Krajnc N, Riedl K, Altmann P, et al
Retinal Layer Thinning After Optic Neuritis is Associated With Future Relapse
Remission in Relapsing Multiple Sclerosis.
Neurology. 2022 Aug 2. pii: WNL.0000000000200970.
Rev Neurol (Paris)
- CHEDID T, Moisset X, Clavelou P
Rationale for off-label treatments use in primary progressive multiple sclerosis:
A review of the literature.
Rev Neurol (Paris). 2022 Jul 15. pii: S0035-3787(22)00639.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016